Benefit-harm trade-offs of intensive versus standard blood pressure control: pooled individual-participant analysis

Pooling more than 80,000 patients from six major trials, aiming for a lower blood-pressure target cut heart attacks, strokes, heart failure and cardiovascular death, and the overall balance stayed favorable even after accounting for the extra kidney-related and other side effects.